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We have recently identified a novel transduction pathway through which Vas-
cular Endothelial Growth Factor (VEGF) controls experimentally induced neoangio-
genesis, specifically involving endothelial VEGF receptor subtype 2 and the release 
of intracellular calcium from NAADP (Nicotinic Acid Adenosine Dinucleotide Phos-
phate) responsive acidic stores (1). We have now extended this research to an in vivo 
model of tumor angiogenesis and show that the pharmacologic NAADP inhibitor 
Ned-19 (2) impairs the vascularization, growth and metastatic spreading of the very 
aggressive VEGF producing murine tumor, B16 melanoma. In parallel in vitro experi-
ments, we tested whether Ned-19 could directly affect the production of VEGF by the 
tumor cells, and found that treatment of B16 cells with Ned-19 unexpectedly results 
in increased VEGF release. These observations indicate that in our model 1) tumor 
angiogenesis is impaired by Ned-19 even in the presence of increased exposure to 
VEGF and 2) that NAADP system is active also in B16 melanoma cells. On the basis 
of this second observation further possible direct effects of Ned-19 on melanoma cell 
aggressiveness such as growth and invasivity are presently investigated and prelimi-
nary results suggest that NAADP system inhibition could potentially represent a two-
fold therapeutic strategy, directly targeting both tumor angiogenesis and tumor cell 
growth.
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